# Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication

> **NCT00101998** · PHASE2 · COMPLETED · sponsor: **Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)** · enrollment: 233 (actual)

## Conditions studied

- Constipation
- Bowel Dysfunction

## Interventions

- **DRUG:** alvimopan
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00101998
- **Lead sponsor:** Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-10-01
- **Primary completion:** 2006-05-01
- **Final completion:** 2006-05-01
- **Target enrollment:** 233 (ACTUAL)
- **Last updated:** 2017-08-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00101998

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00101998, "Study Of Alvimopan Drug For Treatment Of Constipation Due To Prescription Pain Medication". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00101998. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*